X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (803) 803
Publication (184) 184
Patent (50) 50
Book Chapter (13) 13
Book / eBook (9) 9
Book Review (5) 5
Newspaper Article (4) 4
Web Resource (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (377) 377
index medicus (233) 233
hematology (201) 201
multiple myeloma (190) 190
oncology (183) 183
multiple myeloma - drug therapy (141) 141
multiple myeloma - pathology (125) 125
animals (109) 109
male (105) 105
female (96) 96
mice (94) 94
cancer (91) 91
cell line, tumor (91) 91
article (90) 90
bortezomib (89) 89
multiple myeloma - genetics (87) 87
middle aged (75) 75
multiple myeloma - metabolism (74) 74
aged (70) 70
apoptosis (67) 67
abridged index medicus (61) 61
multiple myeloma - therapy (58) 58
tumor cells, cultured (54) 54
adult (51) 51
expression (51) 51
apoptosis - drug effects (50) 50
human necessities (50) 50
hygiene (50) 50
medical or veterinary science (50) 50
preparations for medical, dental, or toilet purposes (50) 50
mice, scid (49) 49
multiple myeloma - immunology (48) 48
therapy (47) 47
prognosis (45) 45
antineoplastic agents - pharmacology (44) 44
multiple-myeloma (42) 42
activation (41) 41
lymphoid neoplasia (41) 41
dexamethasone (40) 40
treatment outcome (39) 39
survival (38) 38
antineoplastic agents - therapeutic use (37) 37
chemistry (37) 37
metallurgy (36) 36
antineoplastic combined chemotherapy protocols - therapeutic use (35) 35
gene expression profiling (35) 35
genetic aspects (35) 35
thalidomide - analogs & derivatives (35) 35
nf-kappa-b (34) 34
cells (33) 33
lenalidomide (33) 33
stem-cell transplantation (33) 33
thalidomide (33) 33
xenograft model antitumor assays (33) 33
bone-marrow (32) 32
health aspects (32) 32
mutation (32) 32
care and treatment (31) 31
gene expression (31) 31
cell biology (30) 30
peptides (30) 30
research (30) 30
immunotherapy (29) 29
specific therapeutic activity of chemical compounds ormedicinal preparations (29) 29
bone marrow (28) 28
cell proliferation (28) 28
growth (28) 28
aged, 80 and over (27) 27
biochemistry (27) 27
boronic acids - pharmacology (27) 27
drug-resistance (27) 27
hemic and lymphatic diseases (27) 27
multidisciplinary sciences (27) 27
multiple myeloma - mortality (27) 27
pyrazines - pharmacology (27) 27
transplantation (27) 27
in-vitro (26) 26
myeloma (26) 26
dose-response relationship, drug (25) 25
cell proliferation - drug effects (24) 24
gene expression regulation, neoplastic (24) 24
development and progression (23) 23
drug synergism (23) 23
interleukin-6 (23) 23
monoclonal gammopathy (23) 23
analysis (22) 22
chemotherapy (22) 22
organic chemistry (22) 22
phosphorylation (22) 22
proteins (22) 22
beer (21) 21
boronic acids - therapeutic use (21) 21
enzymology (21) 21
gene-expression (21) 21
in-vivo (21) 21
interleukin-6 - pharmacology (21) 21
life sciences (21) 21
microbiology (21) 21
mutation or genetic engineering (21) 21
plasma-cells (21) 21
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (882) 882
French (23) 23
German (8) 8
Japanese (5) 5
Chinese (4) 4
Hindi (1) 1
Norwegian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, p. e0174517
The cardiac conduction system (CCS) is composed of specialized cardiomyocytes that initiate and maintain cardiac rhythm. Any perturbation to the normal... 
HEART | CELL-ADHESION MOLECULE | AXONIN-1 | CONTACTIN | MULTIDISCIPLINARY SCIENCES | JUNCTIONS | TACHYCARDIA | MICE | TBX5 | EXPRESSION | PURKINJE-FIBERS | Brugada Syndrome - genetics | Gene Targeting | Haploinsufficiency - genetics | Contactin 2 - genetics | Brugada Syndrome - physiopathology | Heart Conduction System | Humans | Contactin 2 - biosynthesis | Mice, Transgenic | Arrhythmias, Cardiac - physiopathology | Phenotype | Animals | Heart Ventricles - physiopathology | Homologous Recombination - genetics | Myocytes, Cardiac - metabolism | Heart Ventricles - metabolism | Mice | 3' Untranslated Regions | Cardiac Conduction System Disease | Integrases - genetics | Arrhythmias, Cardiac - genetics | Disease Models, Animal | Physiological aspects | Development and progression | Genetic aspects | Research | Arrhythmia | Gene expression | Heart | Conduction | Cardiac arrhythmia | Neurosciences | Transcription factors | Homologous recombination | Spatial discrimination | Recombinase | Neurogenesis | Cell adhesion & migration | Proteins | Position effects | Transgenic animals | Rodents | Cardiology | Heart diseases | Immunoglobulins | Preservation | Internal medicine | Mechanical properties | Cardiomyocytes | Artificial chromosomes | Cre recombinase | Haploinsufficiency | Medicine | Spatial distribution | 3' Untranslated regions | Reagents | Genetic engineering | Spinal cord injuries | Ventricle
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. e328 - e346
Journal Article
Circulation, ISSN 0009-7322, 9/2016, Volume 134, Issue 11, pp. 777 - 779
Journal Article
The Cancer Journal, ISSN 1528-9117, 2019, Volume 25, Issue 1, p. 1
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4290 - 4300
Purpose: We study CD38 levels in immunosuppressive CD4(+)CD25(high)Foxp3(+) regulatory T cells (Treg) and further define immunomodulating effects of a... 
IN-VITRO | MICROENVIRONMENT | ONCOLOGY | IMMUNOTHERAPY | LENALIDOMIDE | DARATUMUMAB MONOTHERAPY | PERIPHERAL-BLOOD | PROLIFERATION | ANTITUMOR-ACTIVITY | CARCINOMA | CANCER | Leukocytes, Mononuclear - drug effects | Immunosuppression - methods | Cell Count | Humans | Interleukin-10 - blood | Multiple Myeloma - immunology | Immunologic Memory - drug effects | Transforming Growth Factor beta - blood | ADP-ribosyl Cyclase 1 - blood | T-Lymphocytes, Regulatory - immunology | Multiple Myeloma - drug therapy | Multiple Myeloma - pathology | T-Lymphocytes, Regulatory - drug effects | Antibodies, Monoclonal - administration & dosage | Immunosuppressive Agents - immunology | ADP-ribosyl Cyclase 1 - immunology | Cell Line, Tumor | Female | Gene Expression Regulation, Neoplastic - drug effects | Immunosuppressive Agents - administration & dosage | Immune Tolerance - drug effects | Multiple Myeloma - blood | Plasma | CD8 antigen | Multiple myeloma | Bone marrow transplantation | Recovery of function | Leukocytes (mononuclear) | Lymphocytes T | Immunosuppressive agents | Killer cells | Lymphocytes | CD38 antigen | Interleukin 1 | Bone marrow | Peripheral blood mononuclear cells | CD25 antigen | Foxp3 protein | Inhibition | Natural killer cells | Immunoregulation | Patients | CD4 antigen | Immunosuppression | Experimental design | Interleukin 10 | Lysis | Monoclonal antibodies | Health risk assessment | Cancer | IFNγ | CD107a | bone marrow stromal cells (BMSCs) | natural occurring Tregs (nTregs) | regulatory T (Treg) | CD38 | Isatuximab (Isa) (SAR650984) | PD1 | multiple myeloma (MM) | conventional T (Tcon) | tumor-induced Treg (iTregs)
Journal Article
2013, ISBN 1461452597
Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to... 
Medicine | Toxicology | Oncology
Web Resource
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 966 - 974
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 1 - 16
Journal Article
Blood, ISSN 0006-4971, 05/2015, Volume 125, Issue 20, pp. 3049 - 3058
Journal Article